MedPath

The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome

Phase 3
Completed
Conditions
Turner Syndrome
Interventions
Registration Number
NCT00029159
Lead Sponsor
Thomas Jefferson University
Brief Summary

The purposes of this study are to learn whether treatment with an androgen type hormone will improve the visual-spatial problems associated with Turner syndrome, and to evaluate the effect growth hormone, with and without androgen, has on growth.

Detailed Description

Turner syndrome is associated with short stature, multiple physical stigmata, absent pubertal development, and increased learning problems. This study is designed to (1) examine the effects of sex steroids (androgen and estrogen) on multiple variables including growth rate, GH binding protein, IGF-I, IGFBP3, and cognitive function in the setting of supplemental growth hormone administration and (2) to investigate any synergistic or additive effects of the androgen and estrogen combination versus each alone, on the above variables.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1estrogen-
1androgen-
2estrogen-
2placebo-
Primary Outcome Measures
NameTimeMethod
Cognitive function in girls with Turner Syndrome4 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Thomas Jefferson University Hospital, 1025 Walnut Street, Suite 726

🇺🇸

Philadelphia, Pennsylvania, United States

National Institutes of Health

🇺🇸

Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath